2017
Functional and structural characterisation of 5 missense mutations of the phenylalanine hydroxylase
PECIMONOVA, Martina, Emil POLAK, Frantisek CSICSAY, Kamila RÉBLOVÁ, Maja STOJILJKOVIC et. al.Základní údaje
Originální název
Functional and structural characterisation of 5 missense mutations of the phenylalanine hydroxylase
Autoři
PECIMONOVA, Martina (703 Slovensko), Emil POLAK (703 Slovensko), Frantisek CSICSAY (703 Slovensko), Kamila RÉBLOVÁ (203 Česká republika, garant, domácí), Maja STOJILJKOVIC (688 Srbsko), Zdenko LEVARSKI (703 Slovensko), Ludovit SKULTETY (703 Slovensko), Ludevit KADASI (703 Slovensko) a Andrea SOLTYSOVA (703 Slovensko)
Vydání
General physiology and biophysics, BRATISLAVA, General Physiol and Biophysic, 2017, 0231-5882
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10600 1.6 Biological sciences
Stát vydavatele
Slovensko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.479
Kód RIV
RIV/00216224:14740/17:00098089
Organizační jednotka
Středoevropský technologický institut
UT WoS
000412155000001
Klíčová slova anglicky
PAH mutations; Phenylketonuria; Specific activity; Chaperons; Functional study
Štítky
Změněno: 30. 10. 2017 15:45, Mgr. Eva Špillingová
Anotace
V originále
Phenylketonuria (PKU) and hyperphenylalaninemia (HPA) are a group of genetic disorders predominantly caused by mutations in the phenylalanine hydroxylase (PAH) gene. To date, more than 950 variants have been identified, however the pathogenic mechanism of many variants remains unknown. In this study, in silico prediction and in vitro prokaryotic and eukaryotic expression systems were used to functionally characterise five PAH missense variants (p.F233I, p.R270I, p.F331S, p.S350Y, and p.L358F) previously identified in Slovak and Czech patients. p.F233I, p.R270I, and p.S350Y were classified as deleterious mutations since they showed no specific activity in functional assay and no response to chaperone co-expression. Protein levels of these PAH variants were very low when expressed in HepG2 cells, and only p.S350Y responded to BH4 precursor overload by significant increase in PAH monomer, probably due to reduced rate of protein degradation as the result of proper protein folding. Variants p.F331S and p.L358F exerted residual enzymatic activity in vitro. While the first can be classified as probably pathogenic due to its very low protein levels in HepG2 cells, the latter is considered to be mild mutation with protein levels of approximately 17.85% compared to wt PAH. Our findings contribute to better understanding of structure and function of PAH mutated enzymes and optimal treatment of PKU patients carrying these mutations using BH4 supplementation.
Návaznosti
LM2015085, projekt VaV |
| ||
LQ1601, projekt VaV |
|